Philips to Introduce AI-Powered, Helium-Free MRI System at RSNA
Offering a variety of AI-enabled tools to facilitate radiology workflow efficiency, the BlueSeal MRI system is reportedly the first wide bore, helium-free 1.5T MRI platform in the field.
Combining artificial intelligence (AI) enhancements for workflow efficiency with a lightweight design and helium-free operation, Philips will unveil the next-generation BlueSeal MRI system at the upcoming 2024 Radiological Society of North America (RSNA) annual meeting in Chicago.
Emphasizing an eco-friendly design, the BlueSeal 1.5T 70 cm MRI system is up to 1,700 kg lighter than comparable systems and the system’s lack of a need for a vent pipe provides additional flexibility with installation, according to Philips.
The next-generation, helium-free BlueSeal 1.5T MRI system will be introduced by Philips at the upcoming 2024 Radiological Society of North America (RSNA) annual meeting in Chicago. (Image courtesy of Philips.)
Philips emphasized that the BlueSeal MRI system also offers a variety of AI-enabled features including:
• automated planning, scanning and image processing for up to 80 percent of MRI procedures with the SmartExam feature;
• a SmartSpeed feature that enables up to 65 percent higher image resolution without additional scan time; and
• integrated imaging and reading with the cloud-based SmartReading technology, which also facilitates enhanced precision diagnosis of neurological conditions and prostate cancer through partnerships with icometrix and Quibim.
“With AI applications seamlessly integrated into our latest 1.5T BlueSeal scanner, we have now applied AI to every aspect of the MRI workflow – from patient setup and high-resolution image capture to quantitative data extraction, advanced diagnostics, and reporting. With this latest innovation, we continue our commitment to deliver wider access to quality MRI to more patients across multiple settings,” noted Ioannis Panagiotelis, Ph.D., the global business leader of MRI at Philips.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
